-
Palonosetron Hydrochloride: 5-HT3 Evidence
2026-09-02
Palonosetron hydrochloride is a highly selective 5-HT3 receptor antagonist with strong activity at 5-HT3A and 5-HT3AB receptors. Its long half-life supports chemotherapy-induced nausea and vomiting prevention, while transporter assays provide a separate research application for OCT2 and MATE1 renal transporter inhibition.
-
JXE-23 in HCC: Autophagy, Arrest, and Signaling
2026-09-02
A 2024 study identified the fern-derived diterpene JXE-23 as a selective inhibitor of HepG2 hepatocellular carcinoma cell growth, combining G2/M arrest with migration suppression and induction of protective autophagy. Its connection to the CIP2A/p-AKT/c-Myc axis suggests a mechanistic framework for testing JXE-23 and autophagy modulation in anticancer drug research.
-
PD 0332991 (Palbociclib) HCl: Lab Guide
2026-09-01
This scenario-based guide explains how PD 0332991 (Palbociclib) HCl, SKU A8316, can support interpretable cell-cycle, viability, and proliferation experiments. It connects CDK4/6 mechanism, Rb-status selection, formulation, assay controls, and practical vendor evaluation to evidence from product data and published genomics research.
-
PGF2α/PTGFR in Endometrial Breakdown and Vascular Dynamics
2026-09-01
A 2024 Reproductive Sciences study identifies PGF2α signaling through PTGFR as a regulator of endometrial breakdown and vascular permeability in a mouse menstrual-like model. By combining pharmacological inhibition, molecular profiling, histology, and HIF-1α promoter-occupancy analysis, the study proposes a mechanistic HIF-1α–PTGFR axis with relevance to menstrual and reproductive vascular biology.
-
Sulfo-Cy5 NHS Ester for Aqueous Protein Imaging
2026-08-31
Sulfo-Cy5 NHS ester enables amine labeling in aqueous workflows, making it useful for solvent-sensitive proteins, peptide probes, and immune-cell imaging. Its far-red spectral profile and sulfonated structure support clearer detection in assays such as cellular imaging of VLA-4 and nanomedicine response studies.
-
O-GlcNAcylation Rewires Wnt-Driven Bone Formation
2026-08-31
The reference study identifies O-GlcNAcylation as a metabolic relay that connects Wnt stimulation with aerobic glycolysis and osteoblast formation. Its mechanistic centerpiece is O-GlcNAc modification of PDK1 at Ser174, which stabilizes PDK1, redirects glucose toward lactate production, and supports bone formation and fracture healing.
-
Mitoxantrone: ABCG2 and Smarter Assay Design
2026-08-30
Mitoxantrone is a topoisomerase II inhibitor whose cellular activity can be reshaped by ABCG2-mediated drug efflux. This article translates recent marein research into transporter-aware assay strategies for anticancer and antiviral investigations.
-
Danazol Models for HPG-Axis Research
2026-08-29
Danazol enables controlled interrogation of androgen receptor signaling, steroidogenesis, and hypothalamic–pituitary–gonadal axis activation. This guide translates a recent rat precocious-puberty study into practical workflows for endocrine assays, herbal intervention testing, and carefully bounded prostate cancer research.
-
Pitavastatin (NK-104): In Vitro Workflow Guide
2026-08-28
Pitavastatin (NK-104, SKU B1124) provides a defined HMG-CoA reductase inhibitor for in vitro studies of cholesterol biosynthesis. This dossier-guided article covers preparation, controls, QC, and interpretation for cell-based and biochemical workflows; it should not be used as a clinical, therapeutic, or unvalidated animal-dosing protocol.
-
HotStart qPCR Master Mix for RCC Validation
2026-08-28
HotStart qPCR Master Mix enables a pathway-informed qPCR strategy for validating albiflorin responses in renal cell carcinoma models. This guide connects hot-start chemistry, ROX normalization, melt curve analysis, and mechanistic interpretation without confusing transcript changes with signaling activity.
-
Anlotinib Hydrochloride: Mechanism & Research Use
2026-08-27
Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor with strong preclinical activity against VEGFR2-driven angiogenesis and additional activity against PDGFRβ and FGFR1. Evidence supports its use in cancer research assays that measure endothelial cell migration inhibition, capillary tube formation, receptor phosphorylation, and ERK signaling pathway inhibition.
-
Go 6983 and PKC Hyperactivity in Striatal Circuits
2026-08-27
Go 6983, a pan-PKC inhibitor, provides a reversible way to test whether PKC hyperactivity links NLGN1 loss to repetitive behavior. This article translates striatal circuit findings into rigorous assay design while defining the limits of cross-domain interpretation.
-
2-Deoxy-D-glucose: Mechanism, Evidence, and Workflow
2026-08-26
2-Deoxy-D-glucose (2-DG) is a glucose analog used to study glycolysis inhibition, ATP depletion, and metabolic stress. Product benchmarks include concentration-dependent cytotoxicity in KIT-positive GIST models, antiviral activity against PEDV in Vero cells, and formulation guidance for reproducible experiments.
-
Nullscript in Placental Stress Assay Design
2026-08-26
Nullscript is a histone deacetylase inhibitor with a distinctive transcriptional inactivity profile. This article examines how it could serve as a hypothesis-testing perturbation in placental nanoplastic research without overstating evidence from cardiac ischemia/reperfusion models.
-
PKM2 inhibitor (compound 3k) Experimental Workflows
2026-08-25
PKM2 inhibitor (compound 3k) connects glycolysis-focused cancer assays with mechanistic immunometabolism studies. Its reported enzyme, cellular, and xenograft activity supports a practical workflow for testing aerobic glycolysis disruption, tumor cell selectivity, and PKM2-dependent phenotypes.